ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
16 announcements
Walpar Nutritions held its 6th AGM on 23 Sep 2026, approving routine resolutions on auditor re-appointment, director rotations, and related party transactions.
Walpar Nutritions Limited issued a notice for its Annual General Meeting to be held on August 23, 2026. The meeting agenda includes financial statement adoption and RPT approvals.
Walpar Nutritions Limited announced the re-appointment of four Independent Directors and its Statutory Auditor for fresh 60-month terms.
Walpar Nutritions Limited's board appointed statutory auditors for five years, re-appointed four independent directors, and approved holding the 6th AGM on September 23, 2026.
Walpar Nutritions rectified a typographical error in its FY2025 XBRL filing regarding Consolidated Total Tax. The company confirmed no other changes to previously submitted financial information.
Walpar Nutritions clarified that recent stock price volatility is market-driven. The company confirmed no undisclosed price-sensitive information exists as of July 8, 2026.
Walpar Nutritions reported standalone annual revenue of ₹65.44 Crore for the financial year 2026. The filing includes audited standalone and consolidated results with an unmodified opinion.
Walpar Nutritions Limited appointed M/s. Gaurav Bachani & Associates and M/s. Saumil J. Shah & Associates as auditors for twelve months. The board approved these changes during its May 2026 meeting.
Walpar Nutritions Ltd reported revenue from operations of ₹42.3 Cr (+7.9% YoY) and net profit of ₹1.7 Cr (+21.4% YoY) for H2 FY26.
Walpar Nutritions reported audited financial results for the year ended March 31, 2026. The board also appointed new secretarial and internal auditors.
Walpar Nutritions Limited scheduled a board meeting on May 28, 2026, to approve audited half-yearly financial results. The trading window remains closed until May 30, 2026.
Three Executive Directors of Walpar Nutritions resigned effective May 19, 2026, citing pre-occupation. This significant leadership exit requires immediate management succession planning.
Walpar Nutritions Limited clarified that discrepancies in its XBRL financial results for the half-year ended September 30, 2025, were due to clerical errors. The company has submitted rectified XBRL data with corrected EPS and PAT figures to ensure consistency with the consolidated PDF results. There is no impact on the underlying financial statements.
Walpar Nutritions Limited informed the exchange regarding the non-applicability of Corporate Governance Provisions for the quarter ended March 31, 2026. The company is exempt under SEBI Regulation 15(2) due to its listing on the SME Exchange and financial thresholds.
Walpar Nutritions Limited has submitted its Structured Digital Database (SDD) compliance certificates for the financial year ended March 31, 2026. The certificates confirm that the company maintains a non-tamperable database to capture UPSI events as required by SEBI PIT Regulations. No non-compliance was reported for the period.
Walpar Nutritions Limited has submitted its Structured Digital Database (SDD) compliance certificate for the quarter ended March 31, 2026. The filing confirms adherence to SEBI PIT Regulations regarding the tracking of unpublished price-sensitive information. The company reported one required event was captured and no non-compliances were observed.